(Bracket indicates negative value)
1 Year:
1. MAA Capital Guaranteed 2 – (2.43%)
2. MAA Capital Guaranteed 3 – (2.65%)
3. MAA Capital Guaranteed 1 – (2.66%)
4. PRUlink Guaranteed Account – (4.02%)
5. MAA Capital Gtd Asia Pacific – (5.52%)
6. MAA Platinum – (6.08%)
7. Property Plus CG – (7.29%)
8. Saham Amanah Sabah – (11.11%)
9. AMB Dividend Trust – (18.77%)
10. MAA Technology – (21.37%)
11. HLG Consumer Products Sector – (22.28%)
12. AMB Value Trust – (22.92%)
13. AMB Ethical Trust – (23.57%)
14. HLG Trading/Services Sector – (23.63%)
15. Allianz Life Equity Income – (24.26%)
16. Areca Equity Trust – (25.13%)
17. ASM Dana Al-Aiman – (25.85%)
18. MAAKL Dividend – (25.93%)
19. MAAKL Al-Fauzan – (25.95%)
20. AUTB Progress – (26.73%)
3 Year: (Annualized Return)
1. AMB Value Trust – 20.16%
2. OSK-UOB Smart Treasure – 20.11%
3. AMB Ethical Trust – 18.42%
4. Uni Aggressive – 16.79%
5. OSK-UOB Emerg Oppty – 16.30%
6. Saham Amanah Sabah – 15.88%
7. Uni Strategic – 14.38%
8. CMS Islamic – 14.27%
9. OSK-UOB Small Cap Opportunity – 13.99%
10. Public SmallCap – 13.84%
11. Manulife Equity – 12.52%
12. PB Growth – 12.13%
13. TA High Growth – 11.77%
14. HLG Industrial and Tech Sector – 11.75%
15. CIMB Principal Equity – 11.38%
16. OSK-UOB Equity – 11.22%
17. MAAKL Progress – 10.80%
18. MAAKL Growth – 10.78%
19. MAAKL Value – 10.55%
20. Alliance Dana Adib – 10.23%
5 Year: (Annualized Return)
1. PB Growth – 12.83%
2. AMB Value Trust – 12.02%
3. Manulife Equity – 10.35%
4. Public SmallCap – 10.25%
5. AMB Ethical Trust – 9.94%
6. MAAKL Al-Faid – 9.09%
7. OSKUOB Equity – 8.72%
8. Saham Amanah Sabah – 7.98%
9. Public Savings – 7.68%
10. Public Islamic Equity – 7.62%
11. MAA Capital Guaranteed 1 – 7.47%
12. Lion Progressive – 7.09%
13. OSK-UOB KLCI Tracker – 7.03%
14. Public Industry – 6.81%
15. Kenanga Syariah Growth – 6.78%
16. Public Ittikal – 6.51%
17. Kenanga Growth – 6.26%
18. AIA Dana Dinamik – 6.20%
19. AIA Aggressive – 6.16%
20. CIMB-Principal Equity – 6.15%
Source: Lipperweb
Tuesday, November 18, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment